Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Souska Zandi

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Cells|January 22, 2024
Modulation of Extracellular Matrix Composition and Chronic Inflammation with Pirfenidone Promotes Scar Reduction in Retinal Wound RepairLaura Jahnke, Virginie Perrenoud, Souska Zandi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2014
Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigmKousuke Noda, Shintaro Nakao, Souska Zandi, et al.
Investigative Ophthalmology & Visual Science|November 29, 2016
Vitreal Cytokine Profile Differences Between Eyes With Epiretinal Membranes or Macular HolesSouska Zandi, Christoph Tappeiner, Isabel B Pfister, et al.
Investigative Ophthalmology & Visual Science|March 20, 2012
Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltrationShintaro Nakao, Souska Zandi, Nuria Lara-Castillo, et al.
Journal of Ophthalmic & Vision Research|March 22, 2014
Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot studyRamin Nourinia, Hamid Ahmadieh, Mohammad-Hassan Shahheidari, et al.
Translational Vision Science & Technology|August 25, 2020
Risks and Challenges in Interpreting Simultaneous Analyses of Multiple CytokinesIsabel B Pfister, Souska Zandi, Christin Gerhardt, et al.
Expert Opinion on Investigational Drugs|October 30, 2023
Investigational drugs inhibiting complement for the treatment of geographic atrophyLorenzo Ferro Desideri, Dmitri Artemiev, Enrico Bernardi, et al.
The American Journal of Pathology|June 29, 2010
Novel molecular imaging approach for subclinical detection of iritis and evaluation of therapeutic successFang Xie, Dawei Sun, Alexander Schering, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2016
Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2Mahdi Taher, Shintaro Nakao, Souska Zandi, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 19, 2017
Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular DegenerationSouska Zandi, Florian Weisskopf, Justus G Garweg, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cells|January 22, 2024
Modulation of Extracellular Matrix Composition and Chronic Inflammation with Pirfenidone Promotes Scar Reduction in Retinal Wound RepairLaura Jahnke, Virginie Perrenoud, Souska Zandi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2014
Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigmKousuke Noda, Shintaro Nakao, Souska Zandi, et al.
Investigative Ophthalmology & Visual Science|November 29, 2016
Vitreal Cytokine Profile Differences Between Eyes With Epiretinal Membranes or Macular HolesSouska Zandi, Christoph Tappeiner, Isabel B Pfister, et al.
Investigative Ophthalmology & Visual Science|March 20, 2012
Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltrationShintaro Nakao, Souska Zandi, Nuria Lara-Castillo, et al.
Journal of Ophthalmic & Vision Research|March 22, 2014
Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot studyRamin Nourinia, Hamid Ahmadieh, Mohammad-Hassan Shahheidari, et al.
Translational Vision Science & Technology|August 25, 2020
Risks and Challenges in Interpreting Simultaneous Analyses of Multiple CytokinesIsabel B Pfister, Souska Zandi, Christin Gerhardt, et al.
Expert Opinion on Investigational Drugs|October 30, 2023
Investigational drugs inhibiting complement for the treatment of geographic atrophyLorenzo Ferro Desideri, Dmitri Artemiev, Enrico Bernardi, et al.
The American Journal of Pathology|June 29, 2010
Novel molecular imaging approach for subclinical detection of iritis and evaluation of therapeutic successFang Xie, Dawei Sun, Alexander Schering, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2016
Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2Mahdi Taher, Shintaro Nakao, Souska Zandi, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 19, 2017
Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular DegenerationSouska Zandi, Florian Weisskopf, Justus G Garweg, et al.
Pageof 6